Works matching IS 2095-9907 AND DT 2024

Results: 354
    1

    Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 study.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02064-z
    By:
    • Wang, Hongkai;
    • Jiang, Shusuan;
    • Luo, Hong;
    • Zhou, Fangjian;
    • He, Dalin;
    • Ma, Lulin;
    • Guo, Hongqian;
    • Liang, Chaozhao;
    • Chong, Tie;
    • Jiang, Jun;
    • Chen, Zhiwen;
    • Wang, Yong;
    • Zou, Qing;
    • Tian, Ye;
    • Xiao, Jun;
    • Huang, Jian;
    • Chen, Jinchao;
    • Dong, Qiang;
    • Zhang, Xiaoping;
    • Li, Hanzhong
    Publication type:
    Article
    2
    3
    4

    Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432).

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02060-3
    By:
    • Ai, Xinghao;
    • Jia, Bo;
    • He, Zhiyi;
    • Zhang, Junping;
    • Zhuo, Minglei;
    • Zhao, Jun;
    • Wang, Zhe;
    • Zhang, Jiexia;
    • Fan, Zaiwen;
    • Zhang, Xiaotong;
    • Li, Chong;
    • Jin, Feng;
    • Li, Ziming;
    • Ma, Xia;
    • Tang, Hao;
    • Yan, Xiang;
    • Li, Wei;
    • Xiong, Yuanyuan;
    • Yin, Huan;
    • Chen, Rongrong
    Publication type:
    Article
    5
    6
    7

    Malate initiates a proton-sensing pathway essential for pH regulation of inflammation.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02076-9
    By:
    • Chen, Yu-jia-nan;
    • Shi, Rong-chen;
    • Xiang, Yuan-cai;
    • Fan, Li;
    • Tang, Hong;
    • He, Gang;
    • Zhou, Mei;
    • Feng, Xin-zhe;
    • Tan, Jin-dong;
    • Huang, Pan;
    • Ye, Xiao;
    • Zhao, Kun;
    • Fu, Wen-yu;
    • Li, Liu-li;
    • Bian, Xu-ting;
    • Chen, Huan;
    • Wang, Feng;
    • Wang, Teng;
    • Zhang, Chen-ke;
    • Zhou, Bing-hua
    Publication type:
    Article
    8
    9
    10
    11

    Deciphering the molecular basis of lipoprotein recognition and transport by LolCDE.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02067-w
    By:
    • Qiao, Wen;
    • Shen, Chongrong;
    • Chen, Yujiao;
    • Chang, Shenghai;
    • Wang, Xin;
    • Yang, Lili;
    • Pang, Jie;
    • Luo, Qinghua;
    • Zhang, Zhibo;
    • Xiang, Yingxin;
    • Zhao, Chao;
    • Lu, Guangwen;
    • Ding, Bi-Sen;
    • Ying, Binwu;
    • Tang, Xiaodi;
    • Dong, Haohao
    Publication type:
    Article
    12

    Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02087-6
    By:
    • Zhong, Jia;
    • Fei, Kailun;
    • Wu, Lin;
    • Li, Baolan;
    • Wang, Zhijie;
    • Cheng, Ying;
    • Li, Xiaoling;
    • Wang, Xicheng;
    • Han, Liang;
    • Wu, Xiaohong;
    • Fan, Yun;
    • Yu, Yan;
    • Lv, Dongqing;
    • Shi, Jianhua;
    • Huang, Jianjin;
    • Zhou, Shaozhang;
    • Han, Baohui;
    • Sun, Guogui;
    • Guo, Qisen;
    • Ji, Youxin
    Publication type:
    Article
    13
    14

    A predictive language model for SARS-CoV-2 evolution.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02066-x
    By:
    • Ma, Enhao;
    • Guo, Xuan;
    • Hu, Mingda;
    • Wang, Penghua;
    • Wang, Xin;
    • Wei, Congwen;
    • Cheng, Gong
    Publication type:
    Article
    15

    A phase 2 pilot study of umbilical cord blood infusion as an adjuvant consolidation therapy in elderly patients with acute myeloid leukemia.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02065-y
    By:
    • Wang, Jinzeng;
    • Li, Xiaoyang;
    • Liu, Ping;
    • Dai, Yao;
    • Zhu, Hongming;
    • Zhang, Yunxiang;
    • Wu, Min;
    • Yao, Yunying;
    • Liu, Mingzhu;
    • Yu, Shuting;
    • Jiang, Fangying;
    • Wang, Shuai;
    • Mu, Haoran;
    • Jiao, Bo;
    • Yan, Hua;
    • Wu, Wen;
    • Shen, Yang;
    • Li, Junming;
    • Wang, Shengyue;
    • Ren, Ruibao
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Neutrophil diversity and function in health and disease.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02049-y
    By:
    • Zhang, Fengyuan;
    • Xia, Yidan;
    • Su, Jiayang;
    • Quan, Fushi;
    • Zhou, Hengzong;
    • Li, Qirong;
    • Feng, Qiang;
    • Lin, Chao;
    • Wang, Dongxu;
    • Jiang, Ziping
    Publication type:
    Article
    25
    26

    Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02051-4
    By:
    • Wu, Jun-Wei;
    • Zhou, Chen-Fei;
    • Han, Zheng-Xiang;
    • Zhang, Huan;
    • Yan, Jun;
    • Chen, Jun;
    • Wang, Chun-Bin;
    • Qin, Zhi-Quan;
    • Mao, Yong;
    • Tang, Xin-Yu;
    • Zhu, Liang-Jun;
    • Wei, Xiao-Wei;
    • Cui, Dong-Hai;
    • Yang, Xiu-Li;
    • Shi, Min;
    • Zhao, Li-Qin;
    • Jiang, Jin-Ling;
    • Zhu, Wei-You;
    • Wang, Hong-Mei;
    • Wang, Chun
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Epigenetics-targeted drugs: current paradigms and future challenges.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02039-0
    By:
    • Dai, Wanlin;
    • Qiao, Xinbo;
    • Fang, Yuanyuan;
    • Guo, Renhao;
    • Bai, Peng;
    • Liu, Shuang;
    • Li, Tingting;
    • Jiang, Yutao;
    • Wei, Shuang;
    • Na, Zhijing;
    • Xiao, Xue;
    • Li, Da
    Publication type:
    Article
    42

    Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02031-8
    By:
    • Cheng, Ke;
    • Li, Xiaoying;
    • Lv, Wanrui;
    • Zhao, Gang;
    • Zhou, Ruihan;
    • Chang, Chen;
    • Yang, Heqi;
    • Li, Ruizhen;
    • Li, Zhiping;
    • Chen, Ye;
    • Yi, Cheng;
    • Yan, Ouying;
    • Xiao, Chaoxin;
    • Zhang, Yi;
    • Xiong, Junjie;
    • Huang, Zixin;
    • Shao, Weikang;
    • You, Xin;
    • Guo, Wenhao;
    • He, Du
    Publication type:
    Article
    43
    44

    EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02019-4
    By:
    • Bai, Yingnan;
    • Chen, Liming;
    • Guo, Fanghao;
    • Zhang, Jinghong;
    • Hu, Jinlin;
    • Tao, Xuefei;
    • Lu, Qing;
    • Li, Wenyi;
    • Chen, Xueying;
    • Gong, Ting;
    • Qiu, Nan;
    • Jin, Yawei;
    • Yang, Lifan;
    • Lei, Yu;
    • Ruan, Chengchao;
    • Jing, Qing;
    • Cooke, John P.;
    • Wang, Shijun;
    • Zou, Yunzeng;
    • Ge, Junbo
    Publication type:
    Article
    45
    46
    47
    48
    49
    50